Company: DVAX
Filing Date: 2025-04-15
Form Type: PRER14A
Source: 0000930413-25-001254
Chunk: 124

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-15
Form: PRER14A
Chunk 124
---
 M           |
|                 | 2/13/2025        |           14,000 |                    | A                    | M           |
|                 | 2/13/2025        |            4,708 |                    | D                    | F           |
|                 | 2/13/2025        |           42,424 |                    | A                    | A           |
|                 | 2/13/2025        |           70,000 |                    | A                    | A           |
|                 | 2/10/2025        |            4,666 |                    | D                    | M           |
|                 | 2/10/2025        |            4,666 |                    | A                    | M           |
|                 | 2/10/2025        |            1,747 |                    | D                    | F           |
| Paul Cox        | 2/14/2025        |              185 |                    | A                    | A(2)        |

| A-3 |

| (1) | Transaction Codes:                                                                   |
| A:  | Grant, award or other acquisition of securities from the Company (such as an option) |
| F:  | Payment of exercise price or tax liability by delivering or withholding securities   |
| M:  | Exercise or conversion of derivative security                                        |
| S:  | Open market or private sale of non-derivative or derivative security                 |
| (2) | Pursuant to an ESPP Purchase                                                         |

Miscellaneous Information Regarding Participants in the Solicitation

Except as described in the proxy statement
or this Appendix A, to the Company’s knowledge: none of the Participants or their associates (i) during the past ten (10)
years, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); (ii) beneficially owns,
directly or indirectly, any shares or other securities of the Company or any of the Company’s subsidiaries; or (iii) has
a substantial interest, direct or indirect, by security holdings or otherwise, in any matter to be acted upon at the Annual Meeting.
In addition, other than as set forth in this Appendix A or the proxy statement, neither the Company nor any of the Participants
has been within the past year party to any contract, arrangement or understanding with any person with respect to any of our securities,
including, but not limited to, joint ventures, loan or option arrangements, puts or calls,